Innovative mixed reality training platform to be developed for pharmaceutical companies and healthcare

FHS
July 17, 2023
5:31 am

UK immersive technology company FourPlus, along with collaborators Holosphere and the Cell and Gene Therapy Catapult, have been awarded funding from Innovate UK to create and test a mixed reality training platform that enables customised training delivery for pharmaceutical companies and healthcare.

Probe Into Private Equity in Healthcare Launched

Government officials announced a joint investigation into the role of private equity and “corporate profiteering” in healthcare during an online workshop hosted by the Federal

March 7, 2024

Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial Of AWKN-P001 | Psychedelic Invest

AWAKN-P001 Is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for The Treatment of Severe Alcohol Use Disorder Awakn Life Sciences Corp. (NEO:

September 6, 2023

Novo Nordisk to spend $1.2B for new rare disease drug factory in Denmark

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.